Meeting
2023 ASCO Annual Meeting
Phase II study on feasibility of sentinel lymph node biopsy for ycN0 patients treated with primary chemotherapy in cT1-3N1M0 breast cancer (SHARE study).
Authors
Rikiya Nakamura
Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan
Rikiya Nakamura , Shigeki Minami , Noriaki Wada , Tomohiko Aihara , Kimiyasu Yoneyama , Hiroyuki Yasojima , Shinichiro Kashiwagi , Masayuki Yoshida , Takahiro Nakayama , Masaya Kawada , Tomoko Ogawa , Uhi Toh , Sayaka Kuba , Masahiro Kitada , Akimitsu Yamada , Toru Ohtake , Hiroshi Matsumoto , Mari Saito-Oba , Junichi Sakamoto , Shigeru Imoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Local-Regional Therapy
Clinical Trial Registration Number
000030558
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 583)
DOI
10.1200/JCO.2023.41.16_suppl.583
Abstract #
583
Poster Bd #
413
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
ATNEC: A multicenter, randomized trial investigating whether axillary treatment can be avoided in patients with T1-3N1M0 breast cancer with no residual cancer in the lymph glands after neoadjuvant chemotherapy.
First Author: Amit Goyal
Poster
2021 ASCO Annual Meeting
Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy (ATNEC).
First Author: Amit Goyal
Poster
2019 ASCO Annual Meeting
The CAROLE (CArdiac Related Oncologic Late Effects) Study: A Phase II, single-arm feasibility trial.
First Author: Lindsay Puckett
Poster
2015 Breast Cancer Symposium
Locoregional failure rates after mastectomy for breast cancer patients with T1-2 tumors and axillary nodal microscopic metastases.
First Author: Lonika Majithia